Latest Prostate Specific Antigen News
Differential effect of 2012 USPSTF recommendations for primary care providers, urologists.
Rate of unnecessary screening was 15.7% in men 65 years and older.
Prostate cancer is 1.4 times more likely to develop in those with a PSA level of 2.5 ng/mL or higher.
Equal serum prostate-specific antigen and prostate-specific antigen mass despite larger prostates.
A 50% or greater PSA decline at 15 days after start of treatment was associated with increased progression-free and overall survival.
Prostate-specific antigen density, total tumor length are significant predictors.
After, men undergoing prostate needle biopsy more likely to be diagnosed with high-risk disease.
Screening not linked to improved patient survival after transplant; may delay time to listing, transplant.
Researchers say they believe study findings support a hypothesis than ejaculation resulting from sexual intercourse might cause PSA bounce.
Men with a normal PSA upon repeat testing had a 78% lower risk of prostate cancer diagnosis than men with a second abnormal PSA result.
Only 4.5% of Medicare patients on active surveillance or watchful waiting for prostate cancer are monitored as closely as they should be.
The time to PSA progression in men with relapsing or locally advanced PCa was similar with intermittent and continuous androgen deprivation.
PSA doubling time increased from 28 to 76 months in patients performing exercise training.
But whether that's good or bad isn't yet clear
In small study, olaparib targeted gene mutation in men who had failed other therapy.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)
- Twice-Weekly Dialysis May Preserve Residual Kidney Function
- Robotic Nephrectomy of Kidney Tumors With Thrombi Feasible
- How to Prevent Sexual Transmission of Zika Virus
- Parathyroidectomy Cuts Mortality Risk in Patients With Severe SHPT
- Prostate Cancer Diagnosis Ups Risk of Non-Cancer Hospitalizations